PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Accounts Payables (2021 - 2026)

PepGen (PEPG) posted Accounts Payables of $622000.0 for Q1 2026, down 24.33% sequentially from $822000.0 in Q4 2025, and down 76.95% YoY from $2.7 million in Q1 2025.

Analysis

PepGen (PEPG) Accounts Payables (2021 - 2026) Analysis & Trends

PepGen has reported Accounts Payables for 6 years, with the latest figure at $622000.0 in Q1 2026.

  • Quarterly Accounts Payables fell 76.95% year-over-year to $622000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $622000.0 (down 76.95% YoY) and the FY2025 annual result came in at $822000.0, down 53.08% from the prior year.
  • Accounts Payables retreated to $622000.0 in Q1 2026 per PEPG's latest filing, from $822000.0 in the prior quarter.
  • Over five years, Accounts Payables peaked at $7.7 million in Q2 2024 and troughed at $622000.0 in Q1 2026.
  • A 5-year average of $2.6 million and a median of $1.8 million in 2024 frame the typical range for Accounts Payables.
  • The sharpest annual moves came in 2024 and 2025: Accounts Payables jumped 326.5% in 2024, then slumped 88.94% in 2025.
  • Over 5 years, Accounts Payables stood at $1.4 million in 2022, then dropped by 26.21% to $1.0 million in 2023, then soared by 74.33% to $1.8 million in 2024, then slumped by 53.08% to $822000.0 in 2025, then decreased by 24.33% to $622000.0 in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $622000.0, $822000.0, and $766000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 PepGen 217.99 Mn 217.99 Mn - 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 622,000.00
Dec 31, 2025 822,000.00
Sep 30, 2025 766,000.00
Jun 30, 2025 856,000.00
Mar 31, 2025 2.70 Mn
Dec 31, 2024 1.75 Mn
Sep 30, 2024 5.93 Mn
Jun 30, 2024 7.74 Mn
Mar 31, 2024 1.48 Mn
Dec 31, 2023 1.01 Mn
Sep 30, 2023 3.99 Mn
Jun 30, 2023 1.82 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 1.36 Mn
Sep 30, 2022 4.62 Mn
Jun 30, 2022 5.39 Mn
Mar 31, 2022 1.89 Mn
Dec 31, 2021 3.24 Mn